CHESS: Human and Computer Mentors for Prostate Cancer Patients
2 other identifiers
interventional
209
1 country
3
Brief Summary
The aims include:
- CHESS and Cancer Information Mentor will not differ initially (6 weeks) or late in treatment (6 months) in QOL
- CHESS +Cancer Information Mentor will have the largest impact on QOL (initially and late in treatment) and will be significantly better than either CHESS or Cancer Information Mentor alone.
- To measure potential intervening or mediating processes, so that we can determine how CHESS and the Cancer Information Mentor produce associated QOL benefits.
- To conduct exploratory use analyses examining which types of CHESS content, sequential patterns of content use, or other characteristics of use behavior are associated with greater pretest-posttest improvements in QOL.
- To conduct a secondary analysis exploring whether men whose partners have actively used CHESS do better than those whose partners did not use CHESS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable prostate-cancer
Started Jul 2007
Longer than P75 for not_applicable prostate-cancer
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 3, 2007
CompletedFirst Submitted
Initial submission to the registry
August 14, 2007
CompletedFirst Posted
Study publicly available on registry
August 15, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 11, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 11, 2018
CompletedOctober 24, 2018
October 1, 2018
10.9 years
August 14, 2007
October 23, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect of three study conditions on Quality of Life
6 Months
Study Arms (3)
CHESS System
EXPERIMENTALCHESS System - Internet-based computer program for 6 months.
Cancer Information Mentor
EXPERIMENTALCancer Information Mentor - Phone calls to the patient for 6 months.
CHESS System + Cancer Information Mentor
EXPERIMENTALCHESS System + Cancer Information Mentor
Interventions
Internet-based computer program for 6 months.
Phone calls to the patient for 6 months.
Eligibility Criteria
You may qualify if:
- Being within 9 weeks of a primary diagnosis of Stage 1 or Stage 2 prostate cancer
- Being 18 years of age or older
- Being able to read and write English at the 6th grade level (as shown by an ability to understand the informed consent)
You may not qualify if:
- \. Being under 18 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (3)
Hartford Hospital
Hartford, Connecticut, 06102, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, 53792, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cindy Carmack Taylor, PhD
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2007
First Posted
August 15, 2007
Study Start
July 3, 2007
Primary Completion
May 11, 2018
Study Completion
May 11, 2018
Last Updated
October 24, 2018
Record last verified: 2018-10